Search Login Register

Paradoxical Embolism Summary

Description: Blockage of an artery due to passage of a clot (THROMBUS) from a systemic vein to a systemic artery without its passing through the lung which acts as a filter to remove blood clots from entering the arterial circulation. Paradoxical embolism occurs when there is a defect that allows a clot to cross directly from the right to the left side of the heart as in the cases of ATRIAL SEPTAL DEFECTS or open FORAMEN OVALE. Once in the arterial circulation, a clot can travel to the brain, block an artery, and cause a STROKE.

Also Known As: Embolism, Paradoxical; Crossed Embolism; Crossed Embolisms; Embolism, Crossed; Embolisms, Crossed Show All >>

Networked: 97 relevant articles (3 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Paradoxical Embolism

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Warfarin (Coumadin) : 1 outcome in 4 results : FDA 21 Generic
  2. Ice : 1 study in 3 results : IBA
  3. Oral Contraceptives : 3 results : IBA
  4. Anticoagulants : 3 results : IBA
  5. glucuronyl glucosamine glycan sulfate (Vessel) : 3 results : IBA
  6. Tissue Plasminogen Activator (Alteplase) : 2 results : FDA 2
  7. Heparin (Liquaemin) : 2 results : FDA 74 Generic
  8. factor V Leiden : 2 results : IBA
  9. perfluorooctanoic acid : 2 results : IBA
  10. tranilast (N 5') : 2 results : IBA
Show All >>

Diseases Related to Paradoxical Embolism

  1. Patent Foramen Ovale
  2. Atrial Heart Septal Defects (Atrial Septal Defect)
  3. Thrombosis (Thrombus)
  4. Venous Thrombosis (Deep-Vein Thrombosis)
  5. Embolism (Embolus)
Show All >>

Key Therapies for Paradoxical Embolism

Efficacy Chart >>
  1. Septal Occluder Device : 2 outcomes in 4 results
  2. Catheters : 1 study in 15 results
  3. Vena Cava Filters (Inferior Vena Cava Filter) : 4 results
  4. Sclerotherapy : 4 results
  5. Decompression : 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.